Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,134.7
18.5 (0.59%)

 

  • STI Straits Times Index
    3,134.7
    18.5 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.9
    8.7 (0.55%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,664.3
    160.3 (0.61%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,978.7
    -12.3 (-0.41%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,472.9
    265.7 (1.20%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,169.6
    11.4 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,082.8
    14.7 (0.71%)
    Index delayed 20 minutes
  • XAO XAO
    6,843.2
    79.9 (1.18%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 990.1M
  • Value: 1,160.8M
  • Rise: 178
  • Fall: 130
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.091+0.012
AIMS APAC Reit1.370-0.110
Spackman0.017+0.003
Thomson Medical0.060+0.002
Golden Agri-Res0.210-0.005
YZJ Shipbldg SGD0.970-
Genting Sing0.920-
Mapletree Log Tr1.700+0.030
Jiutian Chemical0.014+0.001
SingTel3.170-

World Indices

World Indices
Name Last Change
Nasdaq 8,148.7 +100.1
HSI 26,664.3 +160.3
HSCEI 10,532.2 +32.0
Jakarta 6,169.6 +11.4
Nikkei 225 22,472.9 +265.7
SSE Comp 2,978.7 -12.3
Shanghai A 3,120.6 -13.0
Shanghai B 270.1 +0.2
PSE Comp 0.0
KOSPI 2,082.8 +14.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVA NOVA WELLNESS GROUP BERHAD
Quotes 15 Minutes Delayed. Updated at 16 Oct 2019 16:58
Last (MYR): 0.635 Change: -0.020 High: 0.665 Remarks:
Change (%): -3.05 Low: 0.630
Open 0.660 Yesterday's Close 0.655
Buy Price 0.630 Sell Price 0.635
Buy Volume ('00) 499 Sell Volume ('00) 1,103
Cumulative Volume ('00) 23,874 Cumulative Value 1,544,082
Click to show Stock Prices chart

Latest News

View All News

Key Statistics

EPS (MYR) a 0.03444 Trailing EPS (MYR) e 0.03444 NAV (MYR) b 0.2420
PE a 18.438 Trailing PE f 18.440 Price / NAV b 2.6240
Dividend (MYR) d - Cash In Hand (MYR) g 0.0032 Issued & Paid-up Shares c 317,744,000
Dividend Yield (%) d - Price / Cash In Hand g 198.438 Treasury Shares h -
Beta - 75 Daysi -0.340 R-Squared - 75 Days(%)i 0.06 Market Cap (M) 201.767
Beta - 500 Daysi 1.115 R-Squared - 500 Days (%)i 2.64 Enterprise Value (M) 162.818
Piotroski F Score 7 Exchange Code 0201 Par Value ( $ ) n.a.
52 Weeks Volatility (%) 46.31 6-Month VWAP 0.553 Free Float (%) 25.7
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 May 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVA Bursa 201.767 18.438 18.440 2.6240 -
Industry PHARMACEUTICALS Bursa 494.211 16.140 15.750 1.7264 3.411
Pharmaceuticals: Major Bursa 634.999 9.060 8.886 0.7464 1.025
Local Peer IGBB Bursa 1,901.020 8.067 7.836 0.6351 0.720
Local Peer KOTRA Bursa 273.771 12.334 12.335 1.5902 4.169
Local Peer BIOHLDG Bursa 163.440 14.105 16.165 1.0182 0.579
Global Peer JOHNSON & JOHNSON NYSE 350,587.343 22.919 21.466 5.7677 2.688
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 219,123.846 17.336 19.193 4.2610 1.943
Global Peer MERCK & CO INC NYSE 217,734.715 35.006 23.257 7.8790 2.369
Global Peer PFIZER INC NYSE 201,883.325 18.103 15.960 3.3901 3.908
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 115,997.756 53.919 53.070 8.5620 2.993
Global Peer SANOFI SPON ADR ECH REP 1/2 ORD EUR2 LEVEL II NASDAQ 114,162.881 22.405 27.755 1.7789 2.521
Global Peer ABBVIE INC NYSE 110,146.760 19.471 26.931 -12.8586 5.303
Global Peer ELI LILLY AND COMPANY NYSE 105,908.000 32.769 25.441 38.0890 2.246
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 105,436.597 21.825 18.398 22.9230 4.814
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 97,728.523 15.984 17.019 12.0657 2.167
Other Global Peers BRISTOL-MYERS SQUIBB CO (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), WUXI APPTEC (HKEx), CHINARES PHARMA (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), INNOVENT BIO-B (HKEx), ALLAKOS INC (NASDAQ), HENLIUS-B (HKEx), CMS (HKEx), JUNSHI BIO-B (HKEx), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), RA PHARMACEUTICALS INC (NASDAQ), CHINAGRANDPHARM (HKEx), AKCEA THERAPEUTICS INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), TRICIDA INC (NASDAQ), CSTONE PHARMA-B (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), CANSINOBIO-B (HKEx), ZYMEWORKS INC (NYSE), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), GOSSAMER BIO INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), UNITED LAB (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), PHIBRO ANIMAL HEALTH CORP (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), HUA MEDICINE-B (HKEx), SPRINGWORKS THERAPEUTICS INC (NASDAQ), DOVA PHARMACEUTICALS INC (NASDAQ), PETIQ INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), FUSEN PHARM (HKEx), AKERO THERAPEUTICS INC (NASDAQ), AKORN INC (NASDAQ), BEYONDSPRING INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), LANNETT CO INC (NYSE), MILESTONE PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), AC IMMUNE SA (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), PROVENTION BIO INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), DAWNRAYS PHARMA (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), FORTY SEVEN INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), HOOKIPA PHARMA INC (NASDAQ), NC HEALTHCARE (HKEx), KALEIDO BIOSCIENCES INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), CHARMACY PHAR (HKEx), MILLENDO THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), IMMUNIC INC (NASDAQ), Merck Tbk. (IDX), AVENUE THERAPEUTICS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), Phapros Tbk. (IDX), TREVI THERAPEUTICS INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), AGEX THERAPEUTICS INC (NYSE American), NOVAN INC (NASDAQ), EYENOVIA INC (NASDAQ), PALLA PHARMA LTD (ASX), SPRING BANK PHARMACEUTICALS INC (NASDAQ), NEP INTERLONG (HKEx), ESSA PHARMA INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), Hyphens Pharma (SGX), HOTH THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), TELIGENT INC NEW (NASDAQ), ZOMEDICA PHARMACEUTICALS CORP (NYSE American), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), ENTERA BIO LTD (NASDAQ), MMJ GROUP HOLDINGS LTD (ASX), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), NOXOPHARM LTD (ASX), ACER THERAPEUTICS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), CRESO PHARMA LTD (ASX), SINOLIFE UTD (HKEx), EXOPHARM LTD (ASX), AERPIO PHARMACEUTICALS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), Star Pharm^ (SGX), ADIAL PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), FARMAFORCE LTD (ASX), RACE ONCOLOGY LTD (ASX), GENPREX INC (NASDAQ), Merck Sharp Dohme Pharma Tbk. (IDX), SUDA PHARMACEUTICALS LTD (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), SIENNA BIOPHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), GEMPHIRE THERAPEUTICS INC (NASDAQ), FIJI KAVA LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.025
+4.10 %
10 Days -+0.060
+10.43 %
20 Days -+0.045
+7.63 %
Medium Term Return 3 Months -+0.180
+39.56 %
6 Months -+0.165
+35.11 %
1 Year 0.023+0.090
+20.73 %
Annualised Return Annualised --
+20.73 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.280 - 0.665 Change From 1 Year Low +0.355 % Change From 1 Year Low (%) +126.79
Change From 1 Year High -0.030 % Change From 1 Year High (%) -4.51
2 Years Range 0.280 - 0.820 Change From 2 Years Low +0.355 % Change From 2 Years Low (%) +126.79
Change From 2 Years High -0.185 % Change From 2 Years High (%) -22.56
5 Years Range 0.280 - 0.820 Change From 5 Years Low +0.355 % Change From 5 Years Low (%) +126.79
Change From 5 Years High -0.185 % Change From 5 Years High (%) -22.56
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

IPO Performance

Listing Date 20 Jul 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 50.66 No of Public Offer Shares (M) 81.66 Public Offer Subscription Rate (x) -
IPO Price (MYR) 0.550 First Day Close (MYR) 0.760 First Week Close (MYR) 0.600
Current vs IPO Price (%) +15.45 First Day Gain (%) +38.18 First Week Gain (%) +9.09

Historical Price Data

Date Open High Low Close Volume VWAP
16 Oct 2019 0.660 0.665 0.630 0.635 2,387,400 0.6468
15 Oct 2019 0.640 0.665 0.640 0.655 5,512,600 0.6532
14 Oct 2019 0.610 0.640 0.605 0.635 3,272,600 0.6304
11 Oct 2019 0.600 0.625 0.600 0.610 1,918,600 0.6102
10 Oct 2019 0.600 0.610 0.585 0.600 1,182,300 0.6017
09 Oct 2019 0.605 0.610 0.580 0.595 1,615,800 0.5937
08 Oct 2019 0.615 0.635 0.600 0.610 3,844,000 0.6191
07 Oct 2019 0.595 0.620 0.595 0.610 5,553,800 0.6082
04 Oct 2019 0.585 0.595 0.580 0.590 1,003,000 0.5856
03 Oct 2019 0.565 0.600 0.565 0.580 2,689,600 0.5864
02 Oct 2019 0.570 0.580 0.565 0.575 599,800 0.5717
01 Oct 2019 0.565 0.585 0.565 0.575 1,726,900 0.5755
30 Sep 2019 0.530 0.585 0.530 0.560 2,969,200 0.5655
27 Sep 2019 0.530 0.535 0.520 0.530 685,700 0.5249
26 Sep 2019 0.545 0.545 0.530 0.535 830,300 0.5342
25 Sep 2019 0.570 0.570 0.540 0.545 840,800 0.5518
24 Sep 2019 0.560 0.575 0.560 0.565 633,500 0.5656
23 Sep 2019 0.565 0.565 0.555 0.560 544,700 0.5587
20 Sep 2019 0.580 0.585 0.560 0.570 707,900 0.5678
19 Sep 2019 0.590 0.595 0.565 0.580 880,600 0.5798
18 Sep 2019 0.585 0.600 0.580 0.585 1,702,200 0.5864
17 Sep 2019 0.565 0.590 0.560 0.590 1,725,800 0.5756
Summary
Current 2 Weeks
(03 Oct 2019 to 16 Oct 2019)
0.565 0.665 0.565 0.635 28,979,700 -
Previous 2 Weeks
(19 Sep 2019 to 02 Oct 2019)
0.590 0.665 0.565 0.575 10,419,400 -
4 Weeks from
(19 Aug 2019 to 18 Sep 2019)
0.425 0.665 0.425 0.585 25,230,500 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.